Curcumin is considered a pharmacologically safe agent that may be useful in
cancer chemoprevention and
therapy. Here, we show for the first time that
curcumin effectively induces paraptosis in malignant
breast cancer cell lines, including MDA-MB-435S, MDA-MB-231, and Hs578T cells, by promoting vacuolation that results from swelling and fusion of mitochondria and/or the endoplasmic reticulum (ER). Inhibition of
protein synthesis by
cycloheximide blocked
curcumin-induced vacuolation and subsequent cell death, indicating that
protein synthesis is required for this process. The levels of AIP-1/Alix
protein, a known inhibitor
protein of paraptosis, were progressively downregulated in
curcumin-treated malignant
breast cancer cells, and AIP-1/Alix overexpression attenuated
curcumin-induced death in these cells. ERK2 and JNK activation were positively associated with
curcumin-induced cell death. Mitochondrial
superoxide was shown to act as a critical early signal in
curcumin-induced paraptosis, whereas proteasomal dysfunction was mainly responsible for the paraptotic changes associated with ER dilation. Notably,
curcumin-induced paraptotic events were not observed in normal breast cells, including mammary epithelial cells and MCF-10A cells. Taken together, our findings on
curcumin-induced paraptosis may provide novel insights into the mechanisms underlying the selective anti-
cancer effects of
curcumin against malignant
cancer cells.